SCHEMBL5513588

SCHEMBL5513588

COCCCC[C@@](O)(c1ccccc1Oc1ccccc1)C1CCCN(C(N)=O)C1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1867948 0.94 REN (0.79) REN
SCHEMBL3728074 0.94 REN (0.79) REN
SCHEMBL4290220 0.91 REN (0.77) REN
SCHEMBL4290217 0.91 REN (0.77) REN
SCHEMBL4301219 0.90 REN (0.76) REN
SCHEMBL4301222 0.90 REN (0.76) REN
SCHEMBL1862145 0.90 REN (0.75) REN
SCHEMBL1862146 0.90 REN (0.75) REN
SCHEMBL13010263 0.90 REN (0.75) REN
SCHEMBL8267681 0.88 REN (0.62) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP claimed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO claimed